- Home
- WTFC vs BMRN Comparison
WTFC vs BMRN Comparison
Compare WTFC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTFC
- BMRN
- Stock Information
- Founded
- WTFC 1991
- BMRN 1996
- Country
- WTFC United States
- BMRN United States
- Employees
- WTFC N/A
- BMRN N/A
- Industry
- WTFC Major Banks
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WTFC Finance
- BMRN Health Care
- Exchange
- WTFC Nasdaq
- BMRN Nasdaq
- Market Cap
- WTFC 8.7B
- BMRN 9.9B
- IPO Year
- WTFC N/A
- BMRN 1999
- Fundamental
- Price
- WTFC $127.76
- BMRN $54.90
- Analyst Decision
- WTFC Strong Buy
- BMRN Buy
- Analyst Count
- WTFC 13
- BMRN 19
- Target Price
- WTFC $153.62
- BMRN $90.26
- AVG Volume (30 Days)
- WTFC 480.1K
- BMRN 2.9M
- Earning Date
- WTFC 10-20-2025
- BMRN 10-27-2025
- Dividend Yield
- WTFC 1.56%
- BMRN N/A
- EPS Growth
- WTFC 13.95
- BMRN 59.53
- EPS
- WTFC 10.89
- BMRN 2.68
- Revenue
- WTFC $2,563,182,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- WTFC $17.76
- BMRN $13.32
- Revenue Next Year
- WTFC $5.82
- BMRN $7.51
- P/E Ratio
- WTFC $11.79
- BMRN $20.42
- Revenue Growth
- WTFC 13.69
- BMRN 12.39
- 52 Week Low
- WTFC $89.10
- BMRN $50.76
- 52 Week High
- WTFC $142.04
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- WTFC 46.40
- BMRN 55.73
- Support Level
- WTFC $126.26
- BMRN $50.76
- Resistance Level
- WTFC $133.63
- BMRN $55.34
- Average True Range (ATR)
- WTFC 3.21
- BMRN 1.76
- MACD
- WTFC 0.10
- BMRN 0.33
- Stochastic Oscillator
- WTFC 25.20
- BMRN 67.96
About WTFC Wintrust Financial Corporation
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.